Protagonist Therapeutics Inc buy BiotechBee
Start price
24.06.23
/
70%
€75.50
Target price
31.12.25
€40.00
Performance (%)
-
End price
31.08.23
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | 2.721% | 2.721% | 246.330% |
| iShares Core DAX® | 0.650% | 3.212% | 21.634% |
| iShares Nasdaq 100 | 1.650% | 0.322% | 5.422% |
| iShares Nikkei 225® | 1.232% | 1.549% | 15.333% |
| iShares S&P 500 | 1.413% | 0.282% | 3.125% |
According to BiotechBee what are the pros and cons of Protagonist Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Buy mit Kursziel 40,0
In the thread Trading Protagonist Therapeutics Inc
Buy beendet

